title: Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
authors.forename: Theodore E
authors.initials: TE
authors.lastname: Warkentin
authors.forename: Peter
authors.initials: P
authors.lastname: Margetts
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Connolly
authors.forename: Andre
authors.initials: A
authors.lastname: Lamy
authors.forename: Chris
authors.initials: C
authors.lastname: Ricci
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
mesh_terms: D000368:Aged; D001562:Benzimidazoles / Q000009:adverse effects* / Q000097:blood; D002318:Cardiovascular Diseases / Q000150:complications / Q000601:surgery; D000069604:Dabigatran; D015942:Factor VIIa / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D016896:Treatment Outcome; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D001562:Benzimidazoles; D011994:Recombinant Proteins; D015091:beta-Alanine; C103587:recombinant FVIIa; D015942:Factor VIIa; D000069604:Dabigatran